HLA-B*07:02 A549 Cell Line

Products from BPS Bioscience require a minimum order value above 400€

Application: Use as a control for studying the differences between HLA-B alleles. Study T cell activation and responses to peptides presented by HLA-B*07:02.

Background: Human Leukocyte Antigen-B (HLA-B) is an MHC-I (major histocompatibility complex) heavy chain receptor, composed of HLA-B and β2-microglobulin (B2M). There are over 200 genes encoding HLA variants and this variability plays a critical role in adaptive immunity. HLA-B has been linked to autoimmune disorders and drug reactions. B2M HLA-B*07:02 has been linked to an improved HIV disease progression but contributes to severe adverse drug reaction to TMP-SMX (trimethoprimsulfamethoxazole) associated respiratory failure. The understanding of the association between HLA alleles and diseases will allow a refinement of therapeutic strategies.

Description: The HLA-B*07:02 A549 Cell Line is an A549 human lung cancer cell line generated by selecting a single clone of B2M Knockout A549 cells (#82871) transduced with a lentivirus expressing B2M (beta-2 microglobulin) HLA (human leukocyte antigen)-B*07:02 driven by an EF1a promoter (#82428). This cell line has been validated by flow cytometry.

Host Cell Line: A549 is a human lung alveolar basal carcinoma cell line. Adherent epithelial cells.

Mycoplasma Testing: The cell line has been screened to confirm the absence of Mycoplasma species.

Storage Stability: Cells are shipped in dry ice and should immediately be thawed or stored in liquid nitrogen upon receipt. Do not use a -80°C freezer for long term storage.

Supplied As: Each vial contains ˃1 x 106 cells in 1 ml of Cell Freezing Medium (#79796)

Target: HLA

Uniprot: P01889

Warnings: Avoid freeze/thaw cycles.

Biosafety Level: BSL-1

• Artikelnummer: BPS82472
• Hersteller: BPS Bioscience
• Hersteller Artikelnummer: 82472
• Verpackungseinheit: 2 Vials
• Mengeneinheit: PAK
• Wirt: Human